A Prospective Analysis To Assess The Potential Use Of ECGio In Clinical Practice
PAPP
1 other identifier
observational
10,000
1 country
4
Brief Summary
The goal of this observational study is to learn if an ai-assistive algorithm would be useful in patients who are under suspicion of coronary disease. The main question it aims to answer: What proportion of patients would clinicians see fit to order an ai-assistive algorithm if available for clinical use? Participants will be asked to use clinical judgement as to whether a patient fits a predetermined criteria for use and select them for ai-assistive analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2026
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 12, 2026
CompletedStudy Start
First participant enrolled
February 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 21, 2026
February 12, 2026
February 1, 2026
9 months
February 5, 2026
February 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Usage Proportion
The proportion of patients in which it was deemed appropriate to use the AI-Assistive Algorithm
During or within 1 day, on average, of the patient visit
Study Arms (1)
AI-Assistive Algorithm Usage
This group is the patients who were selected as appropriate for use of the AI-Assistive algorithm.
Interventions
ECGio is the first coronary stenosis detection software utilizing data from just a 10-second electrocardiogram (ECG). ECGs are inexpensive, non-invasive, commonly administered tests, and measure the electrical activity of the heart in "waves". The ECGio diagnostic algorithm is an ECG analytic tool which provides the clinician with information to detect the presence, severity, and location of clinically significant coronary artery disease. This diagnostic algorithm is currently not FDA approved, but once FDA approval is received, the labeling will address the following indication and use.
Eligibility Criteria
This study will be conducted in patients who fall within the guidelines for referral to calcium scoring and present at the Cardiology Consultant's of Philadelphia's Advanced Access Center, or present at one of their clinics for pre-operative screening.
You may qualify if:
- Age ≥ 18 years.
- Patients with medical records stored in a digitized format.
- Presenting between February 1 2026 and October 31 2026.
- Patient meets one of the following criteria:
- Hypertension
- Hyperlipidemia
- Family History of Disease
- Diabetes Mellitus
- High BMI (\>30)
- Smoker (Former or Current)
- Presenting for pre-operative clearance
You may not qualify if:
- Patients with acute coronary syndrome (ACS).
- Patient with prior Coronary Artery Bypass Grafting (CABG)
- Patients whose ECG tracing has extreme noise or artifact to the extent that it would be recommended to redo the tracing.
- Age ≥ 90 years.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Cardiology Consultants of Philadelphia - Rothman Orthopedics
Bensalem, Pennsylvania, 19020, United States
Cardiology Consultants of Philadelphia - Chestnus St
Philadelphia, Pennsylvania, 19107, United States
Cardiology Consultants of Philadelphia
Philadelphia, Pennsylvania, 19148, United States
Cardiology Consultants of Philadelphia - Sproul
Springfield, Pennsylvania, 19064, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Veronica Covalesky, MD
Cardiology Consultants of Philadelphia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 12, 2026
Study Start
February 21, 2026
Primary Completion (Estimated)
November 21, 2026
Study Completion (Estimated)
November 21, 2026
Last Updated
February 12, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share